Children and Young People's Residential Placements Flexible Procurement System (Round 19)

NHS Essex Integrated Care Board is undertaking a Competitive Process under the Health Care Services (Provider Selection Regime) Regulations 2023 for the award of a General Medical Services (GMS) contract for Tollgate Practice, Stanway, Colchester. The Authority seeks a suitably qualified provider to deliver primary medical services to a registered patient population of approximately 10,206 patients. Services will be provided under a nationally prescribed GMS contract from the existing practice premises and will include the delivery of core primary medical services, management of the registered patient list, clinical governance, safeguarding, information governance and integration with local health and care services. This procurement is being undertaken to secure the long-term provision of stable, resilient and high-quality primary medical services for the local population. Due to the fixed practice location, established patient list and requirement for uninterrupted service delivery, bidders must demonstrate the ability to mobilise and maintain an appropriately qualified workforce and robust governance arrangements from contract commencement. The contract will be awarded following evaluation against the key criteria set out in the Health Care Services (Provider Selection Regime) Regulations 2023. The estimated contract value is £21,896,491.60, calculated using a notional 20-year term for valuation purposes only. The contract itself is a perpetual GMS contract and is not time limited. Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk

Sexual health needs in the East Riding are shaped by a combination of demographic, geographic, and health inequality factors. Sexual ill health is closely linked with deprivation, rurality, and limited access to services, contributing to avoidable harm and poorer outcomes for specific population groups. In the East Riding sexually transmitted infections, unplanned pregnancies, and associated complications continue to present a significant impact on individuals and the wider health systemThe Service will support delivery against the three nationally mandated Public Health Outcomes Framework (PHOF) indicators relevant to sexual health: · Under 18 conceptions (PHOF 2.04) · Chlamydia detection among 15-24 year olds (PHOF 3.02) · People presenting with HIV at a late stage of infection (PHOF 3.04) In addition to these national indicators, the Service will deliver a range of outcomes that improve sexual and reproductive health for the East Riding population, with a specific focus on reducing inequalities and addressing local patterns of need

Adult MH - Crisis Alternative (Safe Haven) a Non-Clinical Healthcare Alternative to Urgent Care Service to support Oxfordshire's urgent and emergency care system. The service is intended to prevent avoidable emergency department attendance and hospital admissions, improving patient outcomes and system efficiency. The key objectives are: -Improve clinical outcomes and patient experience -Reduce pressure on ED and inpatient services -Deliver value for money and system efficiency -Support integrated urgent care pathways Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk

Nova Education Trust is a forward-thinking multi-academy trust committed to delivering exceptional educational outcomes across its family of Trusts. With a strong presence in the East Midlands, the Trust is driven by a shared vision to create transformational teaching and learning experiences that empower every young learner to thrive. Nova Education Trust is seeking to establish a compliant, scalable and outcome-focused Inclusion Centre service across its family of schools. The Trust is seeking a suitably qualified and experienced provider to deliver, manage and continuously develop Inclusion Centre services across one or more schools within the Trust. The service will provide targeted intervention, behaviour support, pastoral support and reintegration programmes for pupils who are at risk of suspension, permanent exclusion, disengagement from education, poor attendance or other barriers to learning. To access this competition: Registered: Login to https://suppliers.multiquote.com and view the opportunity CA18386. Not registered: Visit https://suppliers.multiquote.com then register and quote CA18386 as the reason for registration. Any queries please contact MultiQuote on 020 3920 8054.

Lincolnshire Community Health Services NHS Trust (LCHS) is seeking provider(s) to deliver Community Pharmacy Services through a PSR Competitive Process. The procurement comprises Lot 1: Medicines Supply, Dispensing and Distribution Services and Lot 2: Clinical Pharmacy Support Services. Contract term: 3 years plus up to 2 x 12-month extensions. Providers may bid for one or both Lots. Service commencement date: 01 April 2027. Additional information: To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk Provider Selection Regime (PSR) Competitive Process Lincolnshire Community Health Services NHS Trust (LCHS) is inviting suitably qualified, experienced and competent providers to participate in a Provider Selection Regime (PSR) Competitive Process for the provision of Community Pharmacy Services across Lincolnshire. The procurement is being undertaken in accordance with the Health Care Services (Provider Selection Regime) Regulations 2023 and has been structured to secure high-quality, resilient and sustainable pharmaceutical services that support patient care, medicines optimisation, medicines safety and service delivery across a diverse community healthcare environment. The procurement is divided into two Lots, allowing providers to bid for one Lot, both Lots, or any combination permitted within the procurement documentation: Lot 1 - Medicines Supply, Dispensing and Distribution Services The successful provider will be responsible for the procurement, dispensing, storage, distribution and supply of medicines and associated pharmaceutical products across a wide range of services. The service supports Community Hospitals, Urgent Treatment Centres (UTCs), Community Nursing Services, Integrated Community Teams, Home Visiting Services, Vaccination Services, Sexual Health Services and specialist HIV Services delivered across Lincolnshire and neighbouring areas. The provider will be expected to maintain robust medicines governance arrangements, support urgent and out-of-hours medicines requirements, manage medicines shortages and recalls, and provide a resilient medicines supply chain capable of supporting a geographically dispersed healthcare organisation. Lot 2 - Clinical Pharmacy Support Services The successful provider will deliver a comprehensive clinical pharmacy service supporting Community Hospitals, Urgent Treatment Centres, Butterfly Hospice, Sexual Health Services and HIV Services. Services will include medicines reconciliation, medicines optimisation, clinical pharmacy review, multidisciplinary team support, prescribing support, medicines governance, audit, education and training, patient counselling, specialist HIV pharmacy support and participation in quality improvement initiatives. Providers will be expected to deploy an appropriately skilled workforce comprising pharmacists, independent prescribers and pharmacy technicians capable of delivering consistent and high-quality pharmaceutical care across multiple sites.

The Contracting Authority is seeking to procure a specialist Individual Placement and Support (IPS) service to support adults engaged in structured drug and alcohol treatment services across the six London boroughs of: Croydon Kingston upon Thames Merton Richmond upon Thames Sutton Wandsworth The successful provider will deliver a high-quality IPS employment service that supports individuals receiving treatment for drug and alcohol dependency to obtain and sustain competitive paid employment. The service will operate in accordance with IPS principles and fidelity standards and will work closely with commissioned treatment providers, local authorities, health services, employers and wider stakeholders across South West London.

Expected Outcome: This action will establish a strategic European initiative to develop scalable, modular, and interoperable photonic quantum computing platforms. Proposals for this topic are expected to address and provide credible solutions to at least two major technical roadblocks currently limiting the advancement of photonic quantum computing such as: The lack of deterministic, high-efficiency photonic entanglement and loss-tolerant architectures suitable for fault-tolerant scaling The absence of a standardised, integrated control stack combining photonic hardware, firmware, and system software with reliable benchmarking across platforms Project results are expected to contribute to the following expected outcomes: By 2028, demonstration of a photonic NISQ processor with ≥100 photonic qubits, integrating deterministic single-photon sources, low-loss waveguides, on-chip detectors, and a firmware stack (scheduler, controller, compiler), validated via hardware-agnostic benchmarks and hybrid photonic-HPC applications demonstrating classical-quantum crossover By 2030, delivery of a full-stack, high-connectivity photonic quantum computer, with modular scalability, integrated…

Expected Impact: The action under this topic is expected to achieve the following impacts: Accelerate EU access to more cost-effective interventions in an increasingly ageing population by identifying personalised treatment approaches for elderly-onset immune diseases. Decrease disease risk later in life by defining specific prevention strategies based on ageing biomarkers and risk factors. Halt age-associated disease exacerbation by the identification of predictive and digital biomarkers that can stratify patients for early intervention. Improve quality of life for healthy individuals and patients by preventing further health decline, avoiding escalating care costs, and properly stratifying individuals earlier in the diagnostic pathway. Accelerate adoption of innovative diagnostic, preventative, and therapeutic strategies, strengthening the EU’s position as a healthcare innovator. Evaluate digital biomarker as potential regulatory endpoints in the ultimate goal to develop medicines for ‘healthy ageing’. Integrate fragmented research efforts by bringing together health industry sectors and stakeholders to develop clinical and multi-omics data integration capabilities. Enable new…

Expected Outcome: Proposals are expected to contribute to all following points: The projects must fulfil the performance targets, at the cell and system level, corresponding to the specific targeted application, to be specified in the proposal. Appropriate KPI must be defined for the energy density (volumetric and gravimetric), Power density and C-rate, number of cycles and cost defined under operational conditions. Boost EU competitiveness in next-generation battery technologies for mobility applications. Develop pilot manufacturing capability for next generation lithium-based batteries. Strengthen the EU battery value chain, including new manufacturing equipment, automation, and scalable production processes. Advance the understanding of next-generation battery interfaces at an industrial scale, ensuring manufacturability, durability, and cost-effectiveness. In the case of aviation, the battery requirements should be compatible at minimum with EASA CS.23 (level 4), CS.27 and preferably with CS.25 categories. Scope: This topic will support the scaling-up of next generation (i.e., beyond generation 3) lithium-based batteries (e.g., semi and all-solid state, generation5) from cell…

Expected Outcome: This flagship pilot is the culmination of the entire activity catalogue carried out by the CCAM Partnership since its launch in 2021. It will combine in one project the most promising CCAM use-cases across three key domains, with the technological advancements from all its R&I clusters [1] supporting and enabling CCAM systems and services towards market uptake. This action is expected to contribute to all the following outcomes: Large-scale demonstrations of inclusive, user-oriented, and well-integrated CCAM systems and services for people and goods in mixed traffic through Field Operational Tests (FOTs), Technology Pilots, and Living Labs, building upon advanced and emerging SAE Level 2 systems to move towards SAE Level 3 and 4 functionalities, at multiple test sites and corridors showcasing CCAM potential [2] , for a minimum of 12 months. Validation of enabling technologies that facilitate the extension of Operational Design Domains (ODDs) in large-scale operations and enhance perception performance under poor lighting and adverse weather conditions in large-scale demonstrations and pilots. Assessment of deployment readiness and demonstration of technological…